Brii Biosciences Limited (7SS) — Financial Flexibility Index
Brii Biosciences Limited (7SS) has a Financial Flexibility Index of -5.85x as of December 2025. Free cash flow of €-211.82 Million (operating CF €-338.81 Million minus capex €126.99 Million) represents -6% of total liabilities (€36.20 Million). Check tangible equity quality of Brii Biosciences Limited to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Brii Biosciences Limited Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Brii Biosciences Limited across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Brii Biosciences Limited generate cash.
Annual Financial Flexibility Index for Brii Biosciences Limited (2020–2025)
Year-by-year free cash flow to debt coverage for Brii Biosciences Limited. Explore Brii Biosciences Limited (7SS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.85x | €-211.82 Million | €-338.81 Million | €36.20 Million | ▼ -59.1% |
| 2024 | -3.68x | €-369.66 Million | €-372.89 Million | €100.55 Million | ▲ +15.0% |
| 2023 | -4.33x | €-544.41 Million | €-594.01 Million | €125.87 Million | ▼ -183.9% |
| 2022 | -1.52x | €-356.99 Million | €-496.28 Million | €234.35 Million | ▲ +47.9% |
| 2021 | -2.92x | €-878.43 Million | €-879.46 Million | €300.44 Million | ▼ -2080.4% |
| 2020 | -0.13x | €-403.72 Million | €-403.72 Million | €3.01 Billion | — |